Sonata Scientific Unveils Helios MP500: Breakthrough Ethylene Oxide (EtO) Control Technology for Medical Device Sterilization Facilities

DANBURY, Conn., June 12, 2025 /PRNewswire/ -- Sonata Scientific, a leader in advanced industrial air purification, today announced the launch of its revolutionary Helios MP500, a high-performance solution for eliminating fugitive ethylene oxide (EtO) emissions in medical device sterilization facilities. Tested and validated in real-world environments, the Helios technology platform consistently delivers destruction and removal efficiency (DRE) exceeding 99%, ensuring a safer environment for workers and surrounding communities.

Unlike traditional solutions, the Helios MP500 is a standalone, ductless powerhouse that operates at 500 cubic feet per minute (cfm) while maintaining high-efficiency performance. Initial units have been deployed into the medical device supply chain, and new orders will be accepted beginning July 2025. With scalable manufacturing capabilities, Sonata is prepared to deliver these units in volume to meet global demand.

"This is not just another air purifier – it's a game-changer," said Bob Henderson, Director of Applications Engineering at Sonata Scientific. "Our Helios technology is proven to eliminate fugitive EtO, even in the parts-per-billion (ppb) range where existing systems simply can’t compete."

Helios MP500 is the first in a growing family of EtO control solutions from Sonata Scientific. The company is actively developing additional products to address transportation, warehouses, and distribution centers. Localized enclosures and integrated monitoring technologies will also be addressed to ensure a range of solutions for diverse industry needs. The Helios technology platform, including the MP500, was developed, in part, with funding from the FDA.

"We are in close collaboration with our customers, refining our product roadmap to address their immediate and future needs," said Melissa Petruska, Chief Technical Officer at Sonata Scientific. "This is just the beginning."

About the Grant:

This project is supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award R43FD007588, totaling $1,710,218, with 100 percent funded by FDA. The contents of this press release are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by FDA/HHS, or the U.S. Government. 

About Sonata Scientific

Sonata Scientific is an early-stage company leveraging its expertise in materials chemistry and systems' innovations to develop practical solutions that enhance living and working environments. From advanced air purification to environmental safety, Sonata Scientific is committed to delivering world-class products that make a measurable difference. More information is available on request from Sonata Scientific.

Learn more at:  www.sonatascientific.com or contact us at [email protected]

Media Contact:
Peter Van Buskirk
203-448-6767
[email protected]

SOURCE Sonata Scientific